BioStem Technologies Inc. (BSEM) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for BSEM, including 1 insider trade and 1 13D/G filing. The most recent was published Nov 5, 2026.

BioStem Technologies, Inc. is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain, CryoTek and SteriTek processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national commercial footprint, BioStem is committed to advancing innovation in regenerative medicine.

BSEM rankings

News · 26 weeks2+100%
2026-05-10: 02026-05-17: 02026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 2
2026-05-102026-11-01
Mix290d
  • Insider1(50%)
  • 13D/G1(50%)
Activity · 52 weeks22 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

2 items

BSEM FAQ

6 questions
  • What does BioStem Technologies Inc. do?
    BioStem Technologies, Inc. is a publicly traded, biomedical innovator, focused on developing, manufacturing and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages its industry-leading proprietary BioRetain, CryoTek and SteriTek processing technologies, designed to optimize the preservation of the natural properties of these tissues, supporting their use in clinical settings. Its allografts are used by clinicians across a wide range of specialties. With a growing portfolio of products, expanding clinical research initiatives, and a national...
  • What is the latest news on BSEM?
    In the last 30 days Quantisnow tracked 2 wire items for BSEM: 1 insider trade and 1 13D/G filing. The most recent was published on November 5, 2026.
  • Where does BSEM stock trade?
    BioStem Technologies Inc. (BSEM) is listed on NASDAQ.
  • What sector and industry is BSEM in?
    BioStem Technologies Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • What companies are similar to BSEM?
    Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare BSEM side-by-side with any of them on Quantisnow.
  • How can I track BSEM on Quantisnow?
    Quantisnow aggregates BioStem Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BSEM to receive live email and push alerts on every new disclosure.